EVOKED POTENTIAL STUDY
Visual
Evoked Potential Study (VEP)
Brainstem
Auditory Evoked Potential Study (BAESP)
Somatosensory
Evoked Potential Study (SSEP)
Electronic averaging
has permitted the recording of low amplitude potentials evoked by
different types of sensory stimulus. These responses are commonly
used in the diagnosis of Multiple Sclerosis (M.S), a relapsing and
remitting condition which is characterized by patchy inflammation
affecting the myelin sheath of the central nervous system. The
object is to demonstrate abnormalities in regions of the nervous
system not known from clinical manifestations to be involved -silent
lesions. For example, the finding of abnormal VEPs or BAEPs in a
patient with paraparesis would demonstrate abnormalities in at least
2 sites of the central nervous system characteristic of
M.S.
Visual Evoked Potentials (VEPs)
Brainstem Auditory Evoked Potentials
(BAEPs)
If one could record directly from several different levels of
the subcortical auditory pathway, one would see during the first 10
milliseconds following an appropriate acoustic stimulus a series of
potentials corresponding to the sequential activation of peripheral,
pontomedullary, pontine and midbrain portions of the pathway. When
these acoustic nerve and brainstem potentials are volume conducted
to surface recording electrodes at the vertex and earlobe, they form
a composite series of waves known as brainstem auditory evoked
potentials. Since the amplitude of these responses are very small
(about 1/100 of spontaneous EEG activity), special computer
averaging technique is required.
The neurologic applications of BAEPs have been proven useful
in the diagnosis of M.S.. It may be used as a screening test for
early detection of acoustic neuromas and in the assessment of
comatose patients. Like the VEPs, it may also be a useful screening
test for hearing in the paediatric age group such as neonatal
screening and those who do not cooperate sufficiently with
behavioural testing.
Somatosensory Evoked Potentials (SEPs)
Clinical uses of SEPs
The SEPs findings may help in the detection and localization
of lesions of the central somatosensory pathways but are not
pathognomonic of specific diseases. In Multiple Sclerosis (MS) the
presence of SEP abnormalities may reveal subclinical lesions
involving the central somatosensory pathways thus aiding in early
diagnosis. In patients with definite MS, the incidence of SEP
abnormality is about 80% whereas in the category of possible MS, the
yield is only about 30%. The interpretation of electrophysiologic
results must therefore always be taken in a clinical
context.